|
公司基本資料信息
|
Rivaroxaban | (S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
Rivaroxaban Impurity 1 | 2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione) |
Rivaroxaban Impurity 2 | 1,3-bis(4-(3-oxomorpholino)phenyl)urea |
Rivaroxaban Impurity 3 | N1,N2-bis(((R)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide |
Rivaroxaban Impurity 4 | (S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide |
Rivaroxaban Impurity 5 | (S)-1-(5-chlorothiophene-2-carboxamido)-3-(N-(4-(3-oxomorpholino)phenyl)acetamido)propan-2-yl acetate |
Rivaroxaban Impurity 6 | (S)-2,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-3-carboxamide |
Rivaroxaban Impurity 7 | (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide |
Rivaroxaban Impurity 8 | (S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
Rivaroxaban Impurity 9 | (S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
Rivaroxaban Impurity 10 | 1,3-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)urea |
Rivaroxaban Impurity 11 | (S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)acetamide |
Rivaroxaban Impurity 12 | N1-(((R)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)-N2-(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide |
Rivaroxaban Impurity 13 | (R)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
Sitafloxacin | 7-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 1 | 8-chloro-6,7-difluoro-1-((1S,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 2 | 8-chloro-6,7-difluoro-1-((1R,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 3 | 8-chloro-6,7-difluoro-1-((1S,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 4 | 7-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1S,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 5 | 7-((R)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1S,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 6 | 7-((R)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 7 | 7-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1S,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 8 | 7-((R)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1S,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 9 | 7-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2R)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 10 | 7-((R)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
Sitafloxacin Impurity 11 | 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
10/201 Reteplase Reference Material
13/208 C-Peptide, Human. 63st International Standard.
01/481 Meningococcal serogroup W polysaccharide
13/198 Influenza Antigen B/Massachusetts/02/2076 (Egg derived)
12/B623-056 QCRFLUAH1N1QC1-Influenza AH1N1 QC54
01/508 Meningococcal serogroup W polysaccharide
10/131 Reteplase Reference Material
95/565 Interleukin-26 (Human, rDNA derived)
95/641 Interleukin-102 (Human, rDNA derived)
01/476 Meningococcal serogroup W polysaccharide
13/151 Influenza Antigen B/Massachusetts/02/2029 (Egg derived)
07/348 BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent)
10/107 Reteplase Reference Material
07/297 BCG Vaccine of Russian BCG-I sub-strain(24st WHO Reference Reagent)
01/526 Meningococcal serogroup W polysaccharide
13/170 C-Peptide, Human. 25st International Standard.
03/104-046 HTLV-31 (antibody) Monitor Sample
95/582 Interleukin-43 (Human, rDNA derived)
13/249 Polio Anti Sabin type 32 (inactivated) Serum
13/158 Influenza Antigen B/Massachusetts/02/2036 (Egg derived)
13/154 C-Peptide, Human. 9st International Standard.
95/589 Interleukin-50 (Human, rDNA derived)
12/B623-008 QCRFLUAH1N1QC1-Influenza AH1N1 QC6
01/494 Meningococcal serogroup W polysaccharide
95/561 Interleukin-22 (Human, rDNA derived)
13/171 C-Peptide, Human. 26st International Standard.
01/535 Meningococcal serogroup W polysaccharide
10/142 Reteplase Reference Material
13/167 C-Peptide, Human. 22st International Standard.
01/446 Meningococcal serogroup W polysaccharide
01/490 Meningococcal serogroup W polysaccharide
13/264 Polio Anti Sabin type 47 (inactivated) Serum
95/637 Interleukin-98 (Human, rDNA derived)
13/245 C-Peptide, Human. 100st International Standard.
01/501 Meningococcal serogroup W polysaccharide
13/254 Polio Anti Sabin type 37 (inactivated) Serum
03/104-038 HTLV-23 (antibody) Monitor Sample
13/180 Influenza Antigen B/Massachusetts/02/2058 (Egg derived)
03/104-063 HTLV-48 (antibody) Monitor Sample
13/163 Influenza Antigen B/Massachusetts/02/2041 (Egg derived)
12/B623-064 QCRFLUAH1N1QC1-Influenza AH1N1 QC62
13/209 Influenza Antigen B/Massachusetts/02/2087 (Egg derived)
利伐沙班雜質(zhì),西他沙星雜質(zhì)對(duì)照品 雜質(zhì)對(duì)照品部分產(chǎn)品列表:本頁(yè)面所展現(xiàn)的信息: 利伐沙班雜質(zhì),西他沙星雜質(zhì)對(duì)照品 ,該信息的真實(shí)性、準(zhǔn)確性、合法性由該信息的發(fā)布方: 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 完全負(fù)責(zé)。生化分析儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
友情提醒 :
建議您在購(gòu)買(mǎi)相關(guān)產(chǎn)品前務(wù)必確認(rèn) 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 的資質(zhì)及產(chǎn)品質(zhì)量,過(guò)低的價(jià)格有可能是虛假信息,請(qǐng)謹(jǐn)慎對(duì)待,謹(jǐn)防欺詐行為。
如您發(fā)現(xiàn)該信息內(nèi)有任何違法/侵權(quán)信息,請(qǐng)立即向我們舉報(bào)并提供有效線索。